These results suggest that KRT17 plays a crucial role in the occurrence and metastasis of papillary thyroid carcinoma (Kim et al., 2015) and that it may be a new biomarker and potential therapeutic target. Here, KRT17 is linked to differentiated thyroid carcinoma.